Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cooper Co ( (COO) ) has shared an announcement.
CooperCompanies said on May 4, 2026, that its board has appointed Paul Keel as an independent director, effective July 1, 2026. He will also join the Audit Committee, adding high-level financial oversight experience to the board’s governance structure.
Chair Colleen Jay highlighted Keel’s prior CEO roles in the medical technology and industrial sectors, including Envista Holdings and Smiths Group, and his lengthy leadership tenure at 3M. The appointment signals CooperCompanies’ ambition to bolster strategic execution and global operational capabilities as it seeks to sustain long-term value creation for patients, customers, and shareholders.
The most recent analyst rating on (COO) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on Cooper Co stock, see the COO Stock Forecast page.
Spark’s Take on COO Stock
According to Spark, TipRanks’ AI Analyst, COO is a Neutral.
The score is driven by solid financial health and a positive earnings-call catalyst (raised EPS/FCF guidance and continued capital returns), partially offset by weak technicals (downtrend and negative momentum) and a relatively high P/E with no dividend support.
To see Spark’s full report on COO stock, click here.
More about Cooper Co
CooperCompanies is a leading global medical device company operating through two main business units, CooperVision and CooperSurgical. CooperVision is a major player in the contact lens industry, while CooperSurgical focuses on fertility and women’s healthcare, with the group headquartered in San Ramon, California and selling products in more than 130 countries.
The company employs over 15,000 people worldwide and reports that its products positively impact more than fifty million lives each year. By concentrating on eye care, fertility, and women’s health, CooperCompanies targets long-term structural demand trends across consumer vision correction and specialized medical procedures in developed and emerging markets.
Average Trading Volume: 2,064,837
Technical Sentiment Signal: Sell
Current Market Cap: $12.17B
For detailed information about COO stock, go to TipRanks’ Stock Analysis page.